Free Trial

Cypress Asset Management Inc. TX Invests $5.24 Million in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Cypress Asset Management Inc. TX bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 10,158 shares of the healthcare conglomerate's stock, valued at approximately $5,240,000. UnitedHealth Group comprises about 1.3% of Cypress Asset Management Inc. TX's holdings, making the stock its 23rd largest position.

A number of other hedge funds have also recently modified their holdings of the stock. Capital & Planning LLC grew its holdings in shares of UnitedHealth Group by 19.2% during the fourth quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after buying an additional 79 shares during the last quarter. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Financial Partners Group LLC raised its stake in shares of UnitedHealth Group by 0.5% during the fourth quarter. Financial Partners Group LLC now owns 8,055 shares of the healthcare conglomerate's stock worth $4,074,000 after purchasing an additional 42 shares during the last quarter. MFA Wealth Services acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $512,000. Finally, Motive Wealth Advisors boosted its holdings in shares of UnitedHealth Group by 17.1% in the fourth quarter. Motive Wealth Advisors now owns 755 shares of the healthcare conglomerate's stock valued at $382,000 after acquiring an additional 110 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

UNH has been the topic of several analyst reports. Oppenheimer lowered their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Robert W. Baird lowered their target price on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Finally, TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.

Check Out Our Latest Research Report on UnitedHealth Group

UnitedHealth Group Price Performance

UNH traded down $0.58 during midday trading on Tuesday, reaching $294.99. 20,069,744 shares of the company's stock were exchanged, compared to its average volume of 6,655,522. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $267.60 billion, a PE ratio of 19.03, a P/E/G ratio of 1.37 and a beta of 0.56. The business's 50-day moving average price is $448.25 and its 200 day moving average price is $501.48. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the firm earned $6.91 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Activity at UnitedHealth Group

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
The Hottest AI Stock You Haven’t Bought Yet

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines